Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.36 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | PARL | Q9H300 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL300884 | 0.91 | CA12 (0.42) | ALDH1A1HPGDCA12CA1CA9 | |
| SCHEMBL13455758 | 0.85 | SMN1; SMN2 (0.44) | ALDH1A1HPGDCA12CA1CA9 | |
| SCHEMBL5648489 | 0.84 | CA12 (0.47) | ALDH1A1HPGDCA12CA1CA9 | |
| SCHEMBL27717830 | 0.84 | CA1 (0.55) | ALDH1A1HPGDCA12CA1CA9 | |
| SCHEMBL1696262 | 0.82 | KDM4E (0.42) | ALDH1A1HPGDCA1KMT2AMGLL | |
| SCHEMBL16005095 | 0.82 | ALDH1A1 (0.37) | ALDH1A1HPGDCA12CA1CA9 | |
| SCHEMBL12216547 | 0.82 | LMNA (0.44) | ALDH1A1HPGDCA12CA1CA9 | |
| SCHEMBL1800956 | 0.82 | PTPRF (0.44) | ALDH1A1HPGDCA1LMNASMN1; SMN2 | |
| SCHEMBL3565689 | 0.82 | MAPT (0.42) | ALDH1A1HPGDCA12CA1CA9 | |
| SCHEMBL159204 | 0.82 | KDM4E (0.42) | ALDH1A1HPGDCA1KMT2AMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110672699-A | All-solid-state field effect transistor, biosensor using same and detection method | 天津师范大学 | 2020-01-10 | — | — | CN | claimed |
| CN-110672699-A | All-solid-state field effect transistor, biosensor using same and detection method | 天津师范大学 | 2020-01-10 | — | — | CN | disclosed |
| US-20170096444-A1 | MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER | 2017-04-06 | — | — | US | disclosed |
| US-8093405-B2 | Formation of 18F and 19F fluoroarenes bearing reactive functionalities | UNIVERSITY OF NEWCASTLE UPON TYNE (GB) | 2012-01-10 | — | — | US | disclosed |
| US-20090286992-A1 | FORMATION OF 18F AND 19F FLUOROARENES BEARING REACTIVE FUNCTIONALITIES | UNIVERSITY OF NEWCASTLE UPON TYNE (GB) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170096444-A1 | MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF | DDOST, SI, STT3A | ALDH1A1 4861/4885HPGD 685/4885CA12 291/4885 |
| US-20090286992-A1 | FORMATION OF 18F AND 19F FLUOROARENES BEARING REACTIVE FUNCTIONALITIES | RARB, RARG, RARA | ALDH1A1 533/4885HPGD 3908/4885CA12 316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.